NCT05657041View on ClinicalTrials.gov

Body Weight Adjusted Clopidogrel Treatment in Patients With CORonary Artery Disease

PHASE2/PHASE3UnknownINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

April 26, 2023

Primary Completion Date

August 1, 2024

Study Completion Date

November 1, 2024

Conditions
Coronary Artery DiseasePlatelet Reactivity
Interventions
DRUG

Clopidogrel

Body weight adjusted clopidogrel dosing

Trial Locations (2)

3435CM

NOT_YET_RECRUITING

StAntoniusH, Nieuwegein

Unknown

RECRUITING

St. Antonius Hospital, Nieuwegein

Sponsors
All Listed Sponsors
collaborator

St. Antonius hospital Onderzoeksfonds

UNKNOWN

collaborator

Ace pharmaceuticals

UNKNOWN

collaborator

Allgen pharmaceuticals

UNKNOWN

lead

St. Antonius Hospital

OTHER

NCT05657041 - Body Weight Adjusted Clopidogrel Treatment in Patients With CORonary Artery Disease | Biotech Hunter | Biotech Hunter